Abstract
Aim:
To investigate the role of DKK-1/Wnt/β-catenin signaling in high proliferation of LM-MCF-7 breast cancer cells, a sub-clone of MCF-7 cell line.
Methods:
Two cell lines (MCF-7 and LM-MCF-7) with different proliferation abilities were used. LM-MCF-7 cells were transiently transfected with the pcDNA3-DKK-1 plasmid encoding the DKK-1 gene (or MCF-7 cells were transfected siRNA targeting DKK-1 mRNA). Flow cytometry analysis and 5-bromo-2′-deoxyuridine (BrdU) incorporation assay were applied to detect the cell proliferation. The expression levels of β-catenin, phosphorylated β-catenin, c-Myc, cyclin D1 and Survivin were examined by Western blot analysis. The regulation of Survivin was investigated by Luciferase reporter gene assay.
Results:
Western blot and RT-PCR analysis showed that the expression level of DKK-1 was downregulated in LM-MCF-7 relative to MCF-7 cells. Flow cytometry and BrdU incorporation assay showed DKK-1 could suppress growth of breast cancer cells. Overexpression of DKK-1 was able to accelerate phosphorylation-dependent degradation of β-catenin and downregulate the expression of β-catenin, c-Myc, cyclin D1 and Survivin. Luciferase reporter gene assay demonstrated that Survivin could be regulated by β-catenin/TCF4 pathway.
Conclusion:
We conclude that the downregulation of DKK-1 is responsible for the high proliferation ability of LM-MCF-7 breast cancer cells via losing control of Wnt/β-catenin signaling pathway, in which c-Myc, cyclinD1 and Survivin serve as essential downstream effectors. Our finding provides a new insight into the mechanism of breast cancer cell proliferation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ye L, Wu L, Guo W, Ma H, Zhang X . Screening of a sub-clone of human breast cancer cells with high metastasis potential. Zhonghua Yi Xue Za Zhi 2006; 86: 61–5.
Ye L, You J, Qiao L, Cai N, Wang C, Liu Y, et al. Screening metastasis-associated genes in breast cancer cells with different matastatic ability by cDNA microarray. Prog Biochem Biophys 2005; 32: 421–8.
Zhou X, Liu Y, You J, Zhang H, Zhang X, Ye L . Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 2008; 270: 312–27.
You J, Mi D, Zhou X, Qiao L, Zhang H, Zhang X, et al. A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells. Endocrinology 2009; 150: 1607–17.
Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A . Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005; 20: 539–50.
Yamaguchi N, Oyama T, Ito E, Satoh H, Azuma S, Hayashi M, et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008; 68: 1881–8.
Perez-Nadales E, Lloyd AC . Essential function for ErbB3 in breast cancer proliferation. Breast Cancer Res 2004; 6: 137–9.
Sahoo S, Brickley DR, Kocherginsky M, Conzen SD . Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer. Eur J Cancer 2005; 41: 2754–9.
Lu W, Tinsley HN, Keeton A, Qu Z, Piazza GA, Li Y . Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 2009; 602: 8–14.
Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, et al. Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 2007; 133: 733–7.
Derksen PW, Tjin E, Meijer HP, Klok MD, MacGillavry HD, van Oers MH, et al. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells. Proc Natl Acad Sci USA 2004; 101: 6122–7.
Clevers H . Wnt breakers in colon cancer. Cancer Cell 2004; 5: 5–6.
Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 1999; 274: 19465–72.
Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA . Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 2001; 3: 683–6.
Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002; 417: 664–7.
Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001; 411: 321–5.
Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, et al. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005; 24: 1098–103.
Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 2006; 25: 4116–21.
Bafico A, Liu G, Goldin L, Harris V, Aaronson SA . An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004; 6: 497–506.
Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK . Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 2006; 25: 5027–36.
Yamaguchi Y, Itami S, Watabe H, Yasumoto K, Abdel-Malek ZA, Kubo T, et al. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J Cell Biol 2004; 165: 275–85.
Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD . Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008; 269: 67–77.
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630–6.
Qin X, Zhang H, Zhou X, Wang C, Zhang X, Ye L . Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res 2007; 150: 281–94.
Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET . Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 2005; 65: 7554–60.
Wang FZ, Sha L, Zhang WY, Wu LY, Qiao L, Li N, et al. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol Sin 2007; 28: 431–8.
Chen Z, Li DQ, Tong L, Stewart P, Chu C, Pflugfelder SC . Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells. Mol Vis 2006; 12: 983–94.
Kobayashi K, Ouchida M, Tsuji T, Hanafusa H, Miyazaki M, Namba M, et al. Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 2002; 282: 151–8.
Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM . Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 2006; 25: 6528–37.
Wang J, Shou J, Chen X . Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 2000; 19: 1843–8.
Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE . Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 2007; 9: R63.
Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 2007; 104: 6247–52.
Mikheev AM, Mikheeva SA, Maxwell JP, Rivo JV, Rostomily R, Swisshelm K, et al. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat 2008; 112: 263–73.
He X, Semenov M, Tamai K, Zeng X . LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004; 131: 1663–77.
Spencer CA, Groudine M . Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 1991; 56: 1–48.
Fernando R, Foster JS, Bible A, Strom A, Pestell RG, Rao M, et al. Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1. J Biol Chem 2007; 282: 28864–73.
You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 2004; 64: 5385–9.
Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM . Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 61: 8664–7.
Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 2003; 22: 2729–40.
Lee AY, He B, You L, Xu Z, Mazieres J, Reguart N, et al. Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun 2004; 323: 1246–50.
Acknowledgements
We thank Prof VJ HEARING from the Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, USA, for providing pcDNA3-DKK-1 plasmid. The project was supported by grants of National Basic Research Program of China (973 Program, No 2007CB914802, No 2007CB914804, No 2009CB521702), National Natural Scientific Foundation (No 30770826), and Tianjin Natural Scientific Foundation (No 08JCZDJC20700).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhou, Xl., Qin, Xr., Zhang, Xd. et al. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/β-catenin signaling. Acta Pharmacol Sin 31, 202–210 (2010). https://doi.org/10.1038/aps.2009.200
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.200
Keywords
This article is cited by
-
The role of epigenetic modifications in drug resistance and treatment of breast cancer
Cellular & Molecular Biology Letters (2022)
-
The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling
Acta Pharmacologica Sinica (2018)
-
Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases
Clinical & Experimental Metastasis (2018)
-
The best of both worlds — managing the cancer, saving the bone
Nature Reviews Endocrinology (2016)
-
The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases
Clinical & Experimental Metastasis (2015)
